In addition, it addresses the FDA’s communications With all the applicant, the retention of information that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant could transfer possession of the SE report to a new applicant and electronic submission in the SE report and